Word

KD-PÜR

Status

Registered

Status Code

700

Status Date

Tuesday, March 22, 2022

Serial Number

79294557

Registration Number

6674408

Registration Date

Tuesday, March 22, 2022

Mark Type

4000

Filing Date

Wednesday, July 22, 2020

Published for Opposition

Tuesday, January 4, 2022

Trademark Owner History

K.D. Pharma Bexbach GmbH - Original Registrant

Classifications

40 Contract manufacturing for others of pharmaceutical products, dietary supplements and dietetic products for medical purposes containing omega-3-extracts in the form of oils, powders and capsules

5 Pharmaceutical and veterinary products, namely, pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders, pharmaceutical products for the prevention and treatment of cancer, pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders, pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, for the treatment of bacteria-based diseases, and for the treatment of diabetes, and anti - infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccines, and chemical reagents for medical or veterinary purposes; sanitary preparations for medical use; dietetic foodstuffs and preparations for medical or veterinary purposes, namely, dietetic foods and beverages adapted for medical use, dietetic foods adapted for veterinary use, dietetic beverages adapted for veterinary use, and dietetic preparations adapted for medical purposes; dietary supplements for humans and animals; pharmaceutical products in the nature of oils, powders and capsules containing omega-3-extracts for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; nutritional supplements; dietetic preparations adapted for medical purposes containing omega-3-extracts and in the form of oils, powders and capsules containing omega-3-extracts

42 Scientific and technological services, namely, pharmaceutical research and development, pharmaceutical products development, testing of pharmaceuticals, development of pharmaceutical preparations and medicines, scientific research in the field of pharmaceuticals, pharmaceutical research services, laboratory research services relating to pharmaceuticals, scientific analysis in the field of nutritional supplements; scientific research and development in the field of lipid extraction from natural resources; scientific laboratory services; chemical laboratories; scientific and industrial research for others relating to the manufacture of pharmaceutical products, dietary supplements and dietetic products for medical purposes containing omega-3-extracts in the form of oils, powders and capsules

Trademark Events

Sep 5, 2022

Final Decision Transaction Processed By Ib

Aug 16, 2022

Final Disposition Notice Sent To Ib

Aug 16, 2022

Final Disposition Processed

Jun 22, 2022

Final Disposition Notice Created, To Be Sent To Ib

Mar 22, 2022

Registered-Principal Register

Mar 21, 2022

Notification Of Possible Opposition - Processed By Ib

Mar 2, 2022

Notification Of Possible Opposition Sent To Ib

Mar 2, 2022

Notification Of Possible Opposition Created, To Be Sent To Ib

Jan 22, 2022

Notification Processed By Ib

Jan 4, 2022

Official Gazette Publication Confirmation E-Mailed

Jan 4, 2022

Published For Opposition

Dec 15, 2021

Notification Of Possible Opposition Sent To Ib

Dec 15, 2021

Notice Of Start Of Opposition Period Created, To Be Sent To Ib

Dec 15, 2021

Notification Of Notice Of Publication E-Mailed

Nov 27, 2021

Approved For Pub - Principal Register

Nov 26, 2021

Teas/Email Correspondence Entered

Nov 25, 2021

Correspondence Received In Law Office

Nov 25, 2021

Teas Request For Reconsideration Received

Jun 1, 2021

Data Modification Completed

Jun 1, 2021

Notification Of Final Refusal Emailed

Jun 1, 2021

Final Refusal E-Mailed

Jun 1, 2021

Final Refusal Written

Jun 1, 2021

Assigned To Lie

May 6, 2021

Teas/Email Correspondence Entered

May 6, 2021

Correspondence Received In Law Office

May 6, 2021

Teas Response To Office Action Received

Dec 13, 2020

Refusal Processed By Ib

Nov 25, 2020

Non-Final Action Mailed - Refusal Sent To Ib

Nov 24, 2020

Refusal Processed By Mpu

Nov 8, 2020

Non-Final Action (Ib Refusal) Prepared For Review

Nov 7, 2020

Non-Final Action Written

Nov 6, 2020

Assigned To Examiner

Oct 3, 2020

Application Filing Receipt Mailed

Sep 29, 2020

New Application Office Supplied Data Entered In Tram

Sep 24, 2020

Sn Assigned For Sect 66a Appl From Ib